Literature DB >> 8559380

MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy.

J M Clark1, M P Marks, E Adalsteinsson, D M Spielman, D Shuster, D Horoupian, G W Albers.   

Abstract

We describe the clinical, imaging, and pathologic findings in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). The patient experienced her first stroke-like episode at age forty-four. Brain MRI, obtained at symptom onset, at 3 weeks, and at 1 year, revealed migrating T2-weighted hyperintensities in the temporal/parietal and occipital cortices and later revealed atrophy. Abnormal cerebrovascular reserve was evident on xenon/CT four days after the first MRI. MR spectroscopy at 1 year revealed increased lactate in both the occipital and temporal lobes. Histologic sections demonstrated spongy degeneration of the cortex that was most prominent at the crests of the gyri. Electron microscopy of the blood vessels showed increased numbers of abnormal mitochondria within the vascular smooth muscle and in endothelial cells. We hypothesize that the stroke-like episodes in MELAS may be due to impaired autoregulation secondary to the impaired metabolic activity of mitochondria in the endothelial and smooth muscle cells of blood vessels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8559380     DOI: 10.1212/wnl.46.1.223

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Melas syndrome.

Authors:  S K Singh; D Sarin; J M Puliyel; R Srivastav; R Gupta; N Kumar; A Mathews
Journal:  Indian J Pediatr       Date:  1999 Jul-Aug       Impact factor: 1.967

2.  MELAS/SANDO overlap syndrome associated with POLG1 mutations.

Authors:  Niels Hansen; Thomas Zwarg; Isabel Wanke; Stephan Zierz; Oliver Kastrup; Marcus Deschauer
Journal:  Neurol Sci       Date:  2011-06-07       Impact factor: 3.307

3.  Ischaemia triggered by spreading neuronal activation is inhibited by vasodilators in rats.

Authors:  J P Dreier; G Petzold; K Tille; U Lindauer; G Arnold; U Heinemann; K M Einhäupl; U Dirnagl
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

Review 4.  Migraine and white matter hyperintensities.

Authors:  Alyx Porter; Jonathan P Gladstone; David W Dodick
Journal:  Curr Pain Headache Rep       Date:  2005-08

5.  Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNA.

Authors:  S M Virtanen; M M Lindroos; K Majamaa; P Nuutila; R J Borra; R Parkkola
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-13       Impact factor: 3.825

6.  Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report.

Authors:  Charles B Majoie; Erik M Akkerman; Christian Blank; Peter G Barth; Bwee Tien Poll-The; G J den Heeten
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

7.  Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events.

Authors:  K Abe; H Yoshimura; H Tanaka; N Fujita; T Hikita; S Sakoda
Journal:  Neuroradiology       Date:  2003-12-12       Impact factor: 2.804

Review 8.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

9.  Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema.

Authors:  X Y Wang; K Noguchi; S Takashima; N Hayashi; S Ogawa; H Seto
Journal:  Neuroradiology       Date:  2003-07-25       Impact factor: 2.804

Review 10.  Neuroimaging of mitochondrial disease.

Authors:  Russell P Saneto; Seth D Friedman; Dennis W W Shaw
Journal:  Mitochondrion       Date:  2008-05-23       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.